Search Results - "Pankras, Catherine"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer

    Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer by Chi, Kim N., Spratlin, Jennifer, Kollmannsberger, Christian, North, Scott, Pankras, Catherine, Gonzalez, Martha, Bernard, Apexa, Stieltjes, Hans, Peng, Lixian, Jiao, James, Acharya, Milin, Kheoh, Thian, Griffin, Thomas W., Yu, Margaret K., Chien, Caly, Tran, Nam Phuong

    Published in Journal of clinical pharmacology (01-12-2015)
    “…Food effect on abiraterone pharmacokinetics and safety on abiraterone acetate coadministration with low‐fat or high‐fat meals was examined in healthy subjects…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract A194: A QT/QTc and multi-dose pharmacokinetic (PK) study of abiraterone acetate (AA) plus prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

    Abstract A194: A QT/QTc and multi-dose pharmacokinetic (PK) study of abiraterone acetate (AA) plus prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) by Pili, Roberto, Chi, Kim, Shore, Neal, Papadopoulos, Kyriakos, Smith, Lon, Beeram, Muralidhar, Molina, Arturo, Acharya, Milin, Kheoh, Thian, Jiao, James, Gonzalez, Martha, Pankras, Catherine, Trinh, Angela, Tran, NamPhuong, Tolcher, Anthony

    Published in Molecular cancer therapeutics (12-11-2011)
    “…Abstract Background: AA is the prodrug of abiraterone (A), an androgen biosynthesis inhibitor that selectively inhibits CYP17, thereby blocking testicular,…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: